Balance Sheet for RAPT Therapeutics Inc. (RAPT)

$ 20.25   1.68 (+9.05%) Volume: 126.8k 4:00 PM EDT 5-Jun-2020
After Hours:  $ 20.25 0.00 (0.00%) Volume: 29 4:01 PM EDT 5-Jun-2020
Statement: View:
Assets [+] in Thousands of Dollars
12/2019 12/2018 12/2017 08/2010
Cash and Equivalents 77,383 63,798 47,517 17
Restrictable Cash - - - -
Marketable Securities - - - -
Accounts Receivable - - - -
Loans Receivable - - - -
Other Receivables - - - -
Receivables - - - -
Inventories, Raw Materials - - - -
Inventories, Work in Progress - - - -
Inventories, Purchased Components - - - -
Inventories, Finished Goods - - - -
Inventories, Other - - - -
Inventories, Adjustments & Allowances - - - -
Inventories - - - -
Prepaid Expenses 3,123 1,264 725 -
Current Deferred Income Taxes - - - -
Other Current Assets - - - -
Total Current Assets 80,506 65,062 48,242 17
Land and Improvements - - - -
Buildings and Improvement 3,294 2,989 598 -
Machinery, Furniture and Equipment 6,472 6,139 5,084 -
Construction in Progress - - - -
Fixed Assets, Other - - - 20
Fixed Assets, Total 9,766 9,128 5,682 20
Gross Fixed Assets 9,766 9,128 5,682 20
Accumulated Depreciation (6,059) (4,969) (3,769) (20)
Net Fixed Assets 3,707 4,159 1,913 0
Intangibles - - - -
Cost in Excess - - - -
Non-Current Deferred Income Taxes - - - -
Other Non-Current Assets 389 389 236 -
Total Non-Current Assets 4,096 4,548 2,149 0
Total Assets 84,602 69,610 50,391 18
Liabilities [+] in Thousands of Dollars
12/2019 12/2018 12/2017 08/2010
Accounts Payable 1,143 1,771 1,106 167
Short Term Debt - - - -
Notes Payable - - - -
Accrued Expenses 1,863 1,055 473 -
Accrued Liabilities 1,863 1,055 473 -
Deferred Revenues 4,000 - - -
Current Deferred Income Taxes - - - -
Other Current Liabilities 2,250 1,817 1,669 -
Total Current Liabilities 9,256 4,643 3,248 167
Long Term Debt N/A N/A - -
Deferred Income Tax 2,225 969 905 -
Other Non-Current Liabilities 2,225 969 905 -
Minority Interest - - - -
Capital Lease Obligations - - - -
Preferred Securities of Subsidiary Trust - - - -
Preferred Equity Outside Shareholders' Equity - 161,111 108,643 -
Total Non-Current Liabilities 2,225 162,080 109,548 -
Total Liabilities 11,481 166,723 112,796 167
Preferred Shareholder's Equity - - - -
Common Shareholder's Equity 73,121 (97,113) (62,405) (149)
Common Par 2 1 1 1
Additional Paid in Capital 235,049 22,441 21,005 112
Cumulative Translation Adjustments - - - -
Retained Earnings (161,950) (118,953) (82,806) (262)
Treasury Stock - - - -
Other Equity Adjustments 20 (4) - -
Total Capitalization 73,121 (97,113) (62,405) (149)
Total Equity 73,121 (97,113) (62,405) (149)
Total Liabilities & Shareholder's Equity 84,602 69,610 50,391 18
Cash Flow (43,001) (36,149) (29,115) (133)
Working Capital 71,250 60,419 44,994 (149)
Free Cash Flow (36,362) (36,453) (28,247) (26)
Invested Capital 73,121 (97,113) (62,405) (149)
Shares Outstanding - Common Class Only 21,833 - - 191,457
Preferred Shares Outstanding - - - -
Total Ordinary Shares 21,833 22,750 22,750 9,117
Total Common Shares Outstanding 21,833 - - 191,457
Treasury Shares - - - -
Basic Weighted Shares Outstanding 4,346 17,329 14,461 188,063
Diluted Weighted Shares Outstanding 4,346 17,329 14,461 188,063